Tilo Andus

13.0k total citations · 3 hit papers
119 papers, 10.4k citations indexed

About

Tilo Andus is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Tilo Andus has authored 119 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 44 papers in Epidemiology and 40 papers in Immunology. Recurrent topics in Tilo Andus's work include Inflammatory Bowel Disease (43 papers), Microscopic Colitis (29 papers) and Immune Response and Inflammation (15 papers). Tilo Andus is often cited by papers focused on Inflammatory Bowel Disease (43 papers), Microscopic Colitis (29 papers) and Immune Response and Inflammation (15 papers). Tilo Andus collaborates with scholars based in Germany, Japan and Switzerland. Tilo Andus's co-authors include Peter C. Heinrich, José V. Castell, Gerhard Rogler, Thomas Geiger, Jürgen Schölmerich, Volker Groß, Toshio Hirano, Werner Falk, W. Gerok and Joachim Bauer and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Blood.

In The Last Decade

Tilo Andus

118 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-6 and the acute phase response

1990 2.3k citations Peter C. Heinrich, José V. Castell et al. profile →
Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

1989 745 citations José V. Castell, Tilo Andus et al. FEBS Letters profile →
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa

1998 607 citations Gerhard Rogler, Korbinian Brand et al. Gastroenterology profile →

Peers

Countries citing papers authored by Tilo Andus

Since Specialization

Citations

This map shows the geographic impact of Tilo Andus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilo Andus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilo Andus more than expected).

Fields of papers citing papers by Tilo Andus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilo Andus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilo Andus. The network helps show where Tilo Andus may publish in the future.

Co-authorship network of co-authors of Tilo Andus

This figure shows the co-authorship network connecting the top 25 collaborators of Tilo Andus. A scholar is included among the top collaborators of Tilo Andus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilo Andus. Tilo Andus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Einsatz von spezifischen Antidots bei DOAK-assoziierter schwerer gastrointestinaler Blutung – ein Expertenkonsensus 2023 ·Zeitschrift für Gastroenterologie ·Valentin Fuhrmann, Jürgen Koscielny, (unknown), Tilo Andus, Adam Herber, Stefano Fusco, Elke Roeb, Ingolf Schiefke, Jonas Rosendahl, Matthias Dollinger, Karel Caca, Frank Tacke	1
2	Metabolische und endokrine Funktionen der Zytokine 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Tilo Andus, K.-D. Palitzsch, (unknown), J Schölmerich	0
3	Increased insulin resistance and β cell activity in patients with Crohnʼs disease 2005 ·Inflammatory Bowel Diseases ·N. Bregenzer, A. Hartmann, Ulrike Strauch, Jürgen Schölmerich, Tilo Andus, (unknown)	58
4	Interferon gamma downregulates IL-8 production in primary human colonic epithelial cells without induction of apoptosis 2004 ·International Journal of Colorectal Disease ·Klaus Schlottmann, Frank‐Peter Wachs, Johannes Grossmann, Daniela Vogl, (unknown), Werner Falk, (unknown), Tilo Andus, Gerhard Rogler	10
5	Verdachtsf�lle schwerwiegender Nebenwirkungen nach Infliximab (Remicade�) aus Deutschland 2003 ·Medizinische Klinik ·Tilo Andus, Eduard F. Stange, (unknown), Brigitte Keller‐Stanislawski	13
6	Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: an analysis in 534 patients from two multicenter, prospective GCP-level trials. 2002 ·Pharmacogenetics ·Silvia Mascheretti, Jochen Hampe, Peter J.P. Croucher, Susanna Nikolaus, Tilo Andus, (unknown), Allan Olson, Weihang Bao, Ulrich R. Fölsch, Stefan Schreiber	118
7	Improvement of arthritis/arthralgia after treatment with infliximab (Remicade®) in a German prospective open-label multicenter trial in refractory Crohn's disease 2001 ·Gastroenterology ·Tilo Andus, Hans Herfarth, Florian Obermeier, Tanja Kuehbacher, Silvia Mascheretti, Wolfgang Thriene, Stefan Schreiber	10
8	Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa breakdown → 1998 ·Gastroenterology ·Gerhard Rogler, Korbinian Brand, Daniela Vogl, Sharon Page, Robert Hofmeister, Tilo Andus, Ruth Knuechel, Patrick A. Baeuerle, Jürgen Schölmerich, Volker Groß	607
9	Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease 1998 ·Gut ·(unknown), Tilo Andus, K. W. Ecker, Andreas Raedler, K. Loeschke, Mathias Plauth, J. Rasenack, Alexander N.R. Weber, M Gierend, Klaus Ewe, J Schölmerich, (unknown)	80
10	Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2 1997 ·Gut ·Tilo Andus, R Daig, Daniela Vogl, E Aschenbrenner, G. Lock, S. Hollerbach, M Köllinger, Jürgen Schölmerich, (unknown)	124
11	Steroidinduzierte Myopathie bei linksseitiger Colitis ulcerosa 1997 ·Medizinische Klinik ·I. Caesar, Volker Groß, Michael Roth, Tilo Andus, Werner Hohenberger, Jürgen Schölmerich	2
12	Alterations of the phenotype of colonic macrophages in inflammatory bowel disease 1997 ·European Journal of Gastroenterology & Hepatology ·Gerhard Rogler, Tilo Andus, E Aschenbrenner, Daniela Vogl, Werner Falk, Jürgen Schölmerich, Volker Groß	58
13	[Ambulatory education of patient with Crohn disease/ulcerative colitis]. 1996 ·PubMed ·(unknown), (unknown), Tilo Andus, N. Bregenzer, Volker Groß, Jürgen Schölmerich, (unknown)	18
14	Measurement of tumor necrosis factor alpha mRNA in small numbers of cells by quantitative polymerase chain reaction. 1993 ·PubMed ·Tilo Andus, Ş. Targan, Richard L. Deem, Hiroo Toyoda	24
15	High Concentrations of Soluble Tumor Necrosis Factor Receptors in Ascites 1992 ·Hepatology ·Tilo Andus, Volker Groß, Axel Holstege, (unknown), (unknown), Martina David, Harald Gallati, W. Gerok, Jürgen Schölmerich	47
16	Evidence for continuous stimulation of interleukin-6 production in Crohn's disease 1992 ·Gastroenterology ·Volker Groß, Tilo Andus, I. Caesar, Michael Roth, Jürgen Schölmerich	250
17	O‐ and N‐glycosylation lead to different molecular mass forms of human monocyte interleukin‐6 1989 ·FEBS Letters ·Volker Groß, Tilo Andus, José V. Castell, (unknown), Peter C. Heinrich, W. Gerok	49
18	Action of recombinant human interleukin 6, interleukin 1β and tumor necrosis factor α on the mRNA induction of acute‐phase proteins 1988 ·European Journal of Immunology ·Tilo Andus, Thomas Geiger, Toshio Hirano, T Kishimoto, Peter C. Heinrich	225
19	Cell‐free‐synthesized interleukin‐6 (BSF‐2/IFN‐β2) exhibits hepatocyte‐stimulating activity 1988 ·European Journal of Biochemistry ·Thomas Geiger, Tilo Andus, Joachim Bauer, Hinnak Northoff, Ursula Ganter, Toshio Hirano, Tadamitsu Kishimoto, Peter C. Heinrich	20
20	TUMOR-NECROSIS-FACTOR (TNF), INTERFERON-ALPHA, INTERFERON-GAMMA AND INTERFERON-BETA-1 DO NOT EXHIBIT HEPATOCYTE STIMULATING (HSF) ACTIVITY 1987 ·University of Regensburg Publication Server (University of Regensburg) ·Hinnak Northoff, Tilo Andus, T A Tran-Thi, Willy A. Flegel, Jan Bauer, Daniela N. Männel, Peter C. Heinrich	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact